284 related articles for article (PubMed ID: 31749072)
1. Looking for Drugs in All the Wrong Places: Use of GCPII Inhibitors Outside the Brain.
Vornov JJ; Peters D; Nedelcovych M; Hollinger K; Rais R; Slusher BS
Neurochem Res; 2020 Jun; 45(6):1256-1267. PubMed ID: 31749072
[TBL] [Abstract][Full Text] [Related]
2. A novel PSMA/GCPII-deficient mouse model shows enlarged seminal vesicles upon aging.
Vorlová B; Sedlák F; Kašpárek P; Šrámková K; Malý M; Zámečník J; Šácha P; Konvalinka J
Prostate; 2019 Feb; 79(2):126-139. PubMed ID: 30256431
[TBL] [Abstract][Full Text] [Related]
3. Clinical utility of genetic variants of glutamate carboxypeptidase II in predicting breast cancer and prostate cancer risk.
Naushad SM; Shree Divyya P; Janaki Ramaiah M; Alex Stanley B; Prasanna Lakshmi S; Vishnupriya J; Kutala VK
Cancer Genet; 2015 Nov; 208(11):552-8. PubMed ID: 26471812
[TBL] [Abstract][Full Text] [Related]
4. The therapeutic and diagnostic potential of the prostate specific membrane antigen/glutamate carboxypeptidase II (PSMA/GCPII) in cancer and neurological disease.
Evans JC; Malhotra M; Cryan JF; O'Driscoll CM
Br J Pharmacol; 2016 Nov; 173(21):3041-3079. PubMed ID: 27526115
[TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationships of glutamate carboxypeptidase II (GCPII) inhibitors.
Ferraris DV; Shukla K; Tsukamoto T
Curr Med Chem; 2012; 19(9):1282-94. PubMed ID: 22304717
[TBL] [Abstract][Full Text] [Related]
6. N-acetylaspartylglutamate (NAAG) and glutamate carboxypeptidase II: An abundant peptide neurotransmitter-enzyme system with multiple clinical applications.
Neale JH; Yamamoto T
Prog Neurobiol; 2020 Jan; 184():101722. PubMed ID: 31730793
[TBL] [Abstract][Full Text] [Related]
7. MR-Guided Delivery of Hydrophilic Molecular Imaging Agents Across the Blood-Brain Barrier Through Focused Ultrasound.
Airan RD; Foss CA; Ellens NP; Wang Y; Mease RC; Farahani K; Pomper MG
Mol Imaging Biol; 2017 Feb; 19(1):24-30. PubMed ID: 27481359
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of urea-based inhibitors as active site probes of glutamate carboxypeptidase II: efficacy as analgesic agents.
Kozikowski AP; Zhang J; Nan F; Petukhov PA; Grajkowska E; Wroblewski JT; Yamamoto T; Bzdega T; Wroblewska B; Neale JH
J Med Chem; 2004 Mar; 47(7):1729-38. PubMed ID: 15027864
[TBL] [Abstract][Full Text] [Related]
9. Association of glutamate carboxypeptidase II (GCPII) haplotypes with breast and prostate cancer risk.
Divyya S; Naushad SM; Addlagatta A; Murthy PV; Reddy ChR; Digumarti RR; Gottumukkala SR; Subbarao SA; Kutala VK
Gene; 2013 Mar; 516(1):76-81. PubMed ID: 23266799
[TBL] [Abstract][Full Text] [Related]
10. Mouse glutamate carboxypeptidase II (GCPII) has a similar enzyme activity and inhibition profile but a different tissue distribution to human GCPII.
Knedlík T; Vorlová B; Navrátil V; Tykvart J; Sedlák F; Vaculín Š; Franěk M; Šácha P; Konvalinka J
FEBS Open Bio; 2017 Sep; 7(9):1362-1378. PubMed ID: 28904865
[TBL] [Abstract][Full Text] [Related]
11. Cloning, expression, genomic localization, and enzymatic activities of the mouse homolog of prostate-specific membrane antigen/NAALADase/folate hydrolase.
Bacich DJ; Pinto JT; Tong WP; Heston WD
Mamm Genome; 2001 Feb; 12(2):117-23. PubMed ID: 11210180
[TBL] [Abstract][Full Text] [Related]
12. Parallel Metabolomics and Lipidomics of a PSMA/GCPII Deficient Mouse Model Reveal Alteration of NAAG Levels and Brain Lipid Composition.
Sedlák F; Kvasnička A; Marešová B; Brumarová R; Dobešová D; Dostálová K; Šrámková K; Pehr M; Šácha P; Friedecký D; Konvalinka J
ACS Chem Neurosci; 2024 Apr; 15(7):1342-1355. PubMed ID: 38377674
[TBL] [Abstract][Full Text] [Related]
13. Inhibitor-GCPII Interaction: Selective and Robust System for Targeting Cancer Cells with Structurally Diverse Nanoparticles.
Neburkova J; Sedlak F; Zackova Suchanova J; Kostka L; Sacha P; Subr V; Etrych T; Simon P; Barinkova J; Krystufek R; Spanielova H; Forstova J; Konvalinka J; Cigler P
Mol Pharm; 2018 Aug; 15(8):2932-2945. PubMed ID: 29389139
[TBL] [Abstract][Full Text] [Related]
14. Rational design of urea-based glutamate carboxypeptidase II (GCPII) inhibitors as versatile tools for specific drug targeting and delivery.
Tykvart J; Schimer J; Bařinková J; Pachl P; Poštová-Slavětínská L; Majer P; Konvalinka J; Šácha P
Bioorg Med Chem; 2014 Aug; 22(15):4099-108. PubMed ID: 24954515
[TBL] [Abstract][Full Text] [Related]
15. GCPII variants, paralogs and orthologs.
Hlouchová K; Navrátil V; Tykvart J; Sácha P; Konvalinka J
Curr Med Chem; 2012; 19(9):1316-22. PubMed ID: 22304710
[
